Details
Stereochemistry | RACEMIC |
Molecular Formula | C14H16N2O3 |
Molecular Weight | 260.2884 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ONC(=N)CC(O)COC1=CC=CC2=C1C=CC=C2
InChI
InChIKey=UPZVYDSBLFNMLK-UHFFFAOYSA-N
InChI=1S/C14H16N2O3/c15-14(16-18)8-11(17)9-19-13-7-3-5-10-4-1-2-6-12(10)13/h1-7,11,17-18H,8-9H2,(H2,15,16)
Molecular Formula | C14H16N2O3 |
Molecular Weight | 260.2884 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugfuture.com/chemdata/nadoxolol.html
LD50 in mice (mg/kg): 180 i.v.; 1000 orally
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:55:45 GMT 2023
by
admin
on
Fri Dec 15 15:55:45 GMT 2023
|
Record UNII |
SK43HU1689
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29576
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1866
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | |||
|
SK43HU1689
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | |||
|
Nadoxolol
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | |||
|
SUB09112MIG
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | |||
|
m1212
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | Merck Index | ||
|
C006154
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | |||
|
31462
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | RxNorm | ||
|
CHEMBL357513
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | |||
|
DTXSID90968903
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | |||
|
3322
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | |||
|
100000084409
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | |||
|
54063-51-3
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | |||
|
37333
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY | |||
|
C90798
Created by
admin on Fri Dec 15 15:55:45 GMT 2023 , Edited by admin on Fri Dec 15 15:55:45 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |